Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 7,777-7,788 of 10,612

Drug study icon

CompletedNCT04787302

PET study to Evaluate Target Occupancy of CVL-231 on Brain Receptors Following Oral Dosing

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States, Belgium
Sponsor: Cerevel Therapeutics, LLC
Condition: Schizophrenia

Other study type icon

UnknownNCT04836442

PFI Hazardous Drinkers With Subclinical PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDOtherOver 21 Years

Countries: United States
Sponsor: University of Houston
Condition: PTSD

Drug study icon

CompletedNCT00205725

Pfizer/IVGTT/Ziprasidone/Olanzapine

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Washington University School of Medicine
Condition: Schizophrenia

Drug study icon

CompletedNCT04404192

PH94B in the Treatment of Adjustment Disorder With Anxiety

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AnxietyDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: VistaGen Therapeutics, Inc.
Condition: Anxiety

Drug study icon

CompletedNCT04754802

PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AnxietyDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: VistaGen Therapeutics, Inc.
Condition: Anxiety

Drug study icon

TerminatedNCT05011396

PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AnxietyDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: VistaGen Therapeutics, Inc.
Condition: Anxiety

Behavioral study icon

CompletedNCT05128227

PHARM-S.A.V.E.S: Suicide prevention Training

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SuicidalityBehavioralFrom 18 Years to 99 Years

Countries: United States
Sponsor: University of North Carolina, Chapel Hill
Condition: Suicidality

Behavioral study icon

CompletedNCT06388694

Pharmacist Management of Attention Deficit Hyperactivity Disorder Medication Refill Requests

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDBehavioralFrom 2 Years to 17 Years

Countries: United States
Sponsor: Kaiser Permanente
Condition: ADHD

Behavioral study icon

Active Not RecruitingNCT06411223

Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: Yale University
Condition: Addiction

Behavioral study icon

CompletedNCT05776823

Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: University of Arkansas
Condition: Addiction

Drug study icon

CompletedNCT04411914

Pharmaco-Magnetic Resonance Spectroscopy (MRS) Study of Clavulanic Acid

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: Temple University
Condition: Addiction

Behavioral study icon

Active Not RecruitingNCT04325529

Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.2 (Stress Manipulation)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionBehavioralFrom 18 Years to 45 Years

Countries: United States
Sponsor: Mclean Hospital
Condition: Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.